OpGen received notice of non-compliance from Nasdaq for delayed filings, facing potential delisting

From GlobeNewswire: 2024-05-24 16:05:00

OpGen, Inc. received a notice from Nasdaq, indicating non-compliance with rules due to the Company not filing its Quarterly Report on Form 10-Q, which may lead to delisting. The Company previously failed to meet the Minimum Bid Price Rule and timely file its Annual Report on Form 10-K. Nasdaq granted a deadline extension until June 3, 2024 for compliance. OpGen plans to finalize the Form 10-Q soon to adhere to the rules. The notice does not affect stock trading immediately. OpGen focuses on precision medicine, providing solutions to combat infectious diseases caused by MDROs.



Read more at GlobeNewswire: OpGen Receives Expected Nasdaq Notice Regarding Delayed